STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy

Messenger RNA (mRNA) vaccine is revolutionizing the methodology of immunization in cancer. However, mRNA immunization is drastically limited by multistage biological barriers including poor lymphatic transport, rapid clearance, catalytic hydrolysis, insufficient cellular entry and endosome entrapmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lei, Yi, Wenzhe, Zhang, Zehong, Shan, Xiaoting, Zhao, Zitong, Sun, Xiangshi, Wang, Jue, Wang, Hao, Jiang, Hualiang, Zheng, Mingyue, Wang, Dangge, Li, Yaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484175/
https://www.ncbi.nlm.nih.gov/pubmed/37693123
http://dx.doi.org/10.1093/nsr/nwad214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484175/
https://www.ncbi.nlm.nih.gov/pubmed/37693123
http://dx.doi.org/10.1093/nsr/nwad214

Ejemplares similares